Active
Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery
Type of Sarcoma:
Epithelioid Hemangioendothelioma
Drug:
Trametnib
Accrual Status:
Recruiting
Overall Study Principal Investigator:
Scott Schuetze, MD, PhD
Division of Hematology/Oncology
University of Michigan
Division of Hematology/Oncology
University of Michigan